Quick Takeaways
- Invesco Ltd. filed SCHEDULE 13G for Collegium Pharmaceutical Inc Common Stock (COLL).
- Disclosed ownership: 5.5%.
- Date of event: 31 Dec 2024.
Invesco Ltd. - 31 Dec 2024 SCHEDULE 13G Report for Collegium Pharmaceutical Inc Common Stock (COLL)
- Filing Manager
- Invesco Ltd.
- Reporting Manager
- Invesco Ltd.
- Symbol
- COLL
- Shares outstanding
- 32,286,545 shares
- Disclosed Ownership
- 1,775,760 shares
- Ownership
- 5.5%
- Form type
- SCHEDULE 13G
- Filing time
- 07 Feb 2025, 13:21:57 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 07 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Invesco Ltd. disclosed 5.5% ownership in Collegium Pharmaceutical Inc Common Stock (COLL) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 07 Feb 2025, 13:21.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Invesco Ltd. | 5.5% | 1,775,760 | 1,681,419 | 0 | Robert R. Leveille | Global Head of Compliance |